secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K
Filed at:   2026-06-10T20:54:22+00:00
Accession:  0000950157-26-000700
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Biogen shareholders elect all 10 director nominees and ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- All ten board nominees elected; highest vote against for Eric K. Rowinsky (28.2M against of 121.9M voted).
- PricewaterhouseCoopers ratified as auditor for FY2026 with 124.6M for, 6.6M against.
- Advisory say-on-pay approved with 114.2M for, 7.5M against, 9.4M broker non-votes.
- Meeting held June 9, 2026; results filed on Form 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000095015726000700/0000950157-26-000700-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000095015726000700/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0000950157-26-000700

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer